Mahama urges Africa to invest in local pharmaceutical manufacturing

The President identified a growing African market, import substitution, foreign exchange protection and the African Continental Free Trade Area as key pillars of the business case for domestic pharmaceutical production.

President John Dramani Mahama has urged African countries to accelerate investment in local pharmaceutical manufacturing to reduce the continent’s dependence on imported medicines and vaccines and strengthen its health security.

He argued that the situation presented not only a challenge but also “a significant market opportunity for domestic capital” as African countries seek to build resilient pharmaceutical industries.